BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 11196190)

  • 1. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.
    Jurasz P; Sawicki G; Duszyk M; Sawicka J; Miranda C; Mayers I; Radomski MW
    Cancer Res; 2001 Jan; 61(1):376-82. PubMed ID: 11196190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms.
    Sogo N; Magid KS; Shaw CA; Webb DJ; Megson IL
    Biochem Biophys Res Commun; 2000 Dec; 279(2):412-9. PubMed ID: 11118301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione.
    Gordge MP; Hothersall JS; Noronha-Dutra AA
    Br J Pharmacol; 1998 May; 124(1):141-8. PubMed ID: 9630353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase-2 in platelet adhesion to fibrinogen: interactions with nitric oxide.
    Martinez A; Salas E; Radomski A; Radomski MW
    Med Sci Monit; 2001; 7(4):646-51. PubMed ID: 11433190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet aggregation-induced by caco-2 cells: regulation by matrix metalloproteinase-2 and adenosine diphosphate.
    Medina C; Jurasz P; Santos-Martinez MJ; Jeong SS; Mitsky T; Chen R; Radomski MW
    J Pharmacol Exp Ther; 2006 May; 317(2):739-45. PubMed ID: 16424148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
    Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
    Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial cells play an important role in the antiaggregatory effect of nitric oxide.
    Klinge JM; Topf HG; Trusen B; Rauh M; Rascher W; Dötsch J
    Crit Care Med; 2003 Jul; 31(7):2010-4. PubMed ID: 12847397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide inhibits platelet adhesion to collagen through cGMP-dependent and independent mechanisms: the potential role for S-nitrosylation.
    Irwin C; Roberts W; Naseem KM
    Platelets; 2009 Nov; 20(7):478-86. PubMed ID: 19852686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide regulates IL-8 expression in melanoma cells at the transcriptional level.
    Andrew PJ; Harant H; Lindley IJ
    Biochem Biophys Res Commun; 1995 Sep; 214(3):949-56. PubMed ID: 7575568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relaxation induced by S-nitroso-glutathione and S-nitroso-N-acetylcysteine in rat aorta is not related to nitric oxide production.
    Ceron PI; Cremonez DC; Bendhack LM; Tedesco AC
    J Pharmacol Exp Ther; 2001 Aug; 298(2):686-94. PubMed ID: 11454932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide activates chloride currents in human lung epithelial cells.
    Kamosinska B; Radomski MW; Duszyk M; Radomski A; Man SF
    Am J Physiol; 1997 Jun; 272(6 Pt 1):L1098-104. PubMed ID: 9227510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human platelet aggregation by a novel S-nitrosothiol is abolished by haemoglobin and red blood cells in vitro: implications for anti-thrombotic therapy.
    Megson IL; Sogo N; Mazzei FA; Butler AR; Walton JC; Webb DJ
    Br J Pharmacol; 2000 Dec; 131(7):1391-8. PubMed ID: 11090112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein.
    Calmels S; Hainaut P; Ohshima H
    Cancer Res; 1997 Aug; 57(16):3365-9. PubMed ID: 9269997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
    Liao CH; Cheng JT; Teng CM
    Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators.
    Salvemini D; Currie MG; Mollace V
    J Clin Invest; 1996 Jun; 97(11):2562-8. PubMed ID: 8647949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate.
    Homer KL; Wanstall JC
    Br J Pharmacol; 2002 Dec; 137(7):1071-81. PubMed ID: 12429580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of platelet aggregation by matrix metalloproteinases-9 and -2.
    Fernandez-Patron C; Martinez-Cuesta MA; Salas E; Sawicki G; Wozniak M; Radomski MW; Davidge ST
    Thromb Haemost; 1999 Dec; 82(6):1730-5. PubMed ID: 10613662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide inhibits whole-cell current in cystic fibrosis pancreatic epithelial cells.
    Thethi K; Duszyk M
    Pancreas; 1999 Aug; 19(2):158-66. PubMed ID: 10438163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide inhibition of tobacco catalase and ascorbate peroxidase.
    Clark D; Durner J; Navarre DA; Klessig DF
    Mol Plant Microbe Interact; 2000 Dec; 13(12):1380-4. PubMed ID: 11106031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of platelet aggregation by S-nitroso-cysteine via cGMP-independent mechanisms: evidence of inhibition of thromboxane A2 synthesis in human blood platelets.
    Tsikas D; Ikic M; Tewes KS; Raida M; Frölich JC
    FEBS Lett; 1999 Jan; 442(2-3):162-6. PubMed ID: 9928994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.